Camila Franca

Development of at-home sample collection logistics for large-scale seroprevalence studies.

Aatresh AV, Cummings K, Gerstein H, Knight CS, Limberopolous A, Stasi MA, Bedugnis A, Somberg KA, França CT, Mina MJ.

PLoS One. 2021. 16(11):e0258516. PMID: 34735477

Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b.

Chan LJ, Gandhirajan A, Carias LL, Dietrich MH, Vadas O, Visentin R, França CT, Menant S, Soldati-Favre D, Mueller I, King CL, Tham WH.

Nat Commun. 2021 03 09. 12(1):1538. PMID: 33750786

Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand.

He WQ, Karl S, White MT, Nguitragool W, Monteiro W, Kuehn A, Gruszczyk J, França CT, Sattabongkot J, Lacerda MVG, Tham WH, Mueller I.

PLoS Negl Trop Dis. 2019 08. 13(8):e0007596. PMID: 31425514

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.

He WQ, Shakri AR, Bhardwaj R, França CT, Stanisic DI, Healer J, Kiniboro B, Robinson LJ, Guillotte-Blisnick M, Huon C, Siba P, Cowman A, King CL, Tham WH, Chitnis CE, Mueller I.

PLoS Negl Trop Dis. 2019 02. 13(2):e0006987. PMID: 30768655

Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.

França CT, White MT, He WQ, Hostetler JB, Brewster J, Frato G, Malhotra I, Gruszczyk J, Huon C, Lin E, Kiniboro B, Yadava A, Siba P, Galinski MR, Healer J, Chitnis C, Cowman AF, Takashima E, Tsuboi T, Tham WH, Fairhurst RM, Rayner JC, King CL, Mueller I.

Elife. 2017 09 26. 6. PMID: 28949293

IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.

França CT, Li Wai Suen CSN, Carmagnac A, Lin E, Kiniboro B, Siba P, Schofield L, Mueller I.

Malar J. 2017 09 25. 16(1):386. PMID: 28946883

Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions.

Longley RJ, White MT, Takashima E, Morita M, Kanoi BN, Li Wai Suen CSN, Betuela I, Kuehn A, Sripoorote P, Franca CT, Siba P, Robinson LJ, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I.

PLoS Negl Trop Dis. 2017 Sep. 11(9):e0005888. PMID: 28892517

Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.

Céspedes N, Li Wai Suen CSN, Koepfli C, França CT, Felger I, Nebie I, Arévalo-Herrera M, Mueller I, Corradin G, Herrera S.

PLoS One. 2017. 12(6):e0179863. PMID: 28651021

Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand.

Longley RJ, França CT, White MT, Kumpitak C, Sa-Angchai P, Gruszczyk J, Hostetler JB, Yadava A, King CL, Fairhurst RM, Rayner JC, Tham WH, Nguitragool W, Sattabongkot J, Mueller I.

Malar J. 2017 04 28. 16(1):178. PMID: 28454546

Plasmodium vivax Reticulocyte Binding Proteins Are Key Targets of Naturally Acquired Immunity in Young Papua New Guinean Children.

França CT, He WQ, Gruszczyk J, Lim NT, Lin E, Kiniboro B, Siba PM, Tham WH, Mueller I.

PLoS Negl Trop Dis. 2016 Sep. 10(9):e0005014. PMID: 27677183